- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.41 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x 4U8: 5-(4-tert-butylphenyl)-1-[4-(propan-2-yloxy)phenyl]-1H-indole-2-carboxylic acid(Non-covalent)
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.2: 5 residues within 4Å:- Chain A: I.29, R.63, C.64, L.114
- Ligands: BOG.5
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.60
PEG.8: 5 residues within 4Å:- Chain B: I.29, R.63, C.64, L.114
- Ligands: BOG.11
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.60
PEG.14: 5 residues within 4Å:- Chain C: I.29, R.63, C.64, L.114
- Ligands: BOG.17
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.60
- 3 x GSH: GLUTATHIONE(Non-covalent)
GSH.3: 13 residues within 4Å:- Chain A: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Chain B: A.27, T.30, R.34, L.65
- Ligands: 4U8.1
9 PLIP interactions:3 interactions with chain B, 6 interactions with chain A- Water bridges: B:R.34, B:H.68, A:Y.126
- Salt bridges: B:R.34
- Hydrogen bonds: A:N.70, A:E.73, A:Y.113, A:Y.113, A:R.122
GSH.9: 13 residues within 4Å:- Chain B: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Chain C: A.27, T.30, R.34, L.65
- Ligands: 4U8.7
9 PLIP interactions:3 interactions with chain C, 6 interactions with chain B- Water bridges: C:R.34, C:H.68, B:Y.126
- Salt bridges: C:R.34
- Hydrogen bonds: B:N.70, B:E.73, B:Y.113, B:Y.113, B:R.122
GSH.15: 13 residues within 4Å:- Chain A: A.27, T.30, R.34, L.65
- Chain C: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Ligands: 4U8.13
9 PLIP interactions:6 interactions with chain C, 3 interactions with chain A- Hydrogen bonds: C:N.70, C:E.73, C:Y.113, C:Y.113, C:R.122
- Water bridges: C:Y.126, A:R.34, A:H.68
- Salt bridges: A:R.34
- 6 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
BOG.4: 6 residues within 4Å:- Chain A: A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.6
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:A.134
- Hydrogen bonds: A:S.135, A:Q.139, A:Q.139
- Water bridges: A:S.135, A:S.135
BOG.5: 8 residues within 4Å:- Chain A: K.22, V.25, I.29, T.110, L.114, G.115, K.116
- Ligands: PEG.2
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:K.22, A:V.25, A:T.110
BOG.10: 6 residues within 4Å:- Chain B: A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.12
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.134
- Hydrogen bonds: B:S.135, B:Q.139, B:Q.139
- Water bridges: B:S.135, B:S.135
BOG.11: 8 residues within 4Å:- Chain B: K.22, V.25, I.29, T.110, L.114, G.115, K.116
- Ligands: PEG.8
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:K.22, B:V.25, B:T.110
BOG.16: 6 residues within 4Å:- Chain C: A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.18
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:A.134
- Hydrogen bonds: C:S.135, C:Q.139, C:Q.139
- Water bridges: C:S.135, C:S.135
BOG.17: 8 residues within 4Å:- Chain C: K.22, V.25, I.29, T.110, L.114, G.115, K.116
- Ligands: PEG.14
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:K.22, C:V.25, C:T.110
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
PG4.6: 7 residues within 4Å:- Chain A: V.94, M.97, H.98, L.131, P.132, S.135
- Ligands: BOG.4
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.135
PG4.12: 7 residues within 4Å:- Chain B: V.94, M.97, H.98, L.131, P.132, S.135
- Ligands: BOG.10
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.135
PG4.18: 7 residues within 4Å:- Chain C: V.94, M.97, H.98, L.131, P.132, S.135
- Ligands: BOG.16
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.135
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luz, J.G. et al., Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. J.Med.Chem. (2015)
- Release Date
- 2015-06-10
- Peptides
- Prostaglandin E synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.41 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x 4U8: 5-(4-tert-butylphenyl)-1-[4-(propan-2-yloxy)phenyl]-1H-indole-2-carboxylic acid(Non-covalent)
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- 3 x GSH: GLUTATHIONE(Non-covalent)
- 6 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luz, J.G. et al., Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. J.Med.Chem. (2015)
- Release Date
- 2015-06-10
- Peptides
- Prostaglandin E synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.